BMY.TO – Bristol-Myers Squibb Co

BMY.TO Bristol-Myers Squibb Co

$22.75▲ +1.74% Unknown Other

Volume 701 Avg Volume (10D) –

Key Metrics & Fundamentals

Market Cap

–

P/E Ratio

–

Div Yield

–%

52W Range

22.63 - 22.75

% vs 50 MA

–%

% vs 200 MA

–%

RSI-14

–

Free Cash Flow

$3.09B

Gross Rev

$12.97B

Gross Profit

$9.25B

EBITDA

$4.81B

COGS

$3.73B

Operating Exp

$5.22B

Operating Income

$4.03B

EBIT

$4.03B

Pretax Income

$4.09B

Net Income

$3.32B

Price & Volume History

Zoomed

Loading chart…

Recent News

What Happens To Merck Stock If Keytruda Sales Stop Growing?

Trefis · Oct 20, 2026 10:20 PM ET

Amgen vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?

Motley Fool · Oct 20, 2026 6:05 PM ET

Moderna Jumps 7% While Melanoma Vaccine Data Looms; Bristol Myers Squibb Rises 5%, Pfizer Advances 2%

24/7 Wall St. · Oct 20, 2026 1:53 PM ET

Bristol Myers (BMY) Has New Cancer Wins. Can They Offset the Patent Cliff?

Insider Monkey · Oct 20, 2026 12:31 PM ET

Prothena's Partnership Strategy: Growth Driver or Limitation?

Zacks · Oct 20, 2026 11:34 AM ET

Bristol Myers vs. Eli Lilly: Is BMY’s Deep Valuation Discount Hiding an Opportunity?

Insider Monkey · Oct 20, 2026 8:28 AM ET

Have $1,000 to Invest? This Dirt Cheap Pharma Stock Pays You 4.2% to Wait.

Motley Fool · Oct 20, 2026 7:36 AM ET

StockStory · Oct 20, 2026 5:49 AM ET

European Chip Stocks Resume Fall After Day of Respite

The Wall Street Journal · Oct 20, 2026 4:35 AM ET

Better Dividend Stock: Merck vs. Bristol Myers Squibb

TIKR · Oct 19, 2026 5:31 PM ET

Financial Overview - Income Statement Quarterly

See BMY.TO's money flow as a full page

Social Sentiment

No Reddit posts found for BMY.TO.

AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.